Progress in diagnosis and treatment of pediatric refractory mycoplasma pneumoniae pneumonia
10.3760/cma.j.issn.1673-4408.2020.06.003
- VernacularTitle:儿童难治性肺炎支原体肺炎诊治进展
- Author:
Shaoting XI
1
;
Xuxu CAI
Author Information
1. 中国医科大学附属盛京医院小儿呼吸内科，沈阳 110004
- From:
International Journal of Pediatrics
2020;47(6):384-388
- CountryChina
- Language:Chinese
-
Abstract:
Refractory mycoplasma pneumoniae pneumonia(RMPP) is a common type of community-acquired pneumonia in children which seriously influence children′s physical and mental health.There is no uniform diagnostic criteria.The clinical manifestations were fever, cough and other clinical symptoms 7 days after regular application of macrolides.Lung imaging showed progressive exaceration.Some patients are not treated timely because of lack of specific diagnostic criteria and left pulmonary sequelae eventually, which affect the quality of life seriously.Related researches of RMPP are emerging in recent years.This paper reviews the laboratory diagnosis, pathogenesis, clinical features and treatment of RMPP.
